相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。An Improved Ultrasound-Assisted Extraction Process of Gossypol Acetic Acid From Cottonseed Soapstock
Guangfeng Jia et al.
AICHE JOURNAL (2009)
CELASTROL POTENTIATES RADIOTHERAPY BY IMPAIRMENT OF DNA DAMAGE PROCESSING IN HUMAN PROSTATE CANCER
Yao Dai et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2009)
Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres
Qing Ji et al.
BMC CANCER (2008)
Molecularly Targeted Radiosensitization of Human Prostate Cancer by Modulating Inhibitor of Apoptosis
Yao Dai et al.
CLINICAL CANCER RESEARCH (2008)
NF-kappaB: a potential target for cancer chemoprevention and therapy
Fazlul H. Sarkar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
IAPs: What's in a name?
Srinivasa M. Srinivasula et al.
MOLECULAR CELL (2008)
cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination
Mathieu J. M. Bertrand et al.
MOLECULAR CELL (2008)
A Smac mimetic rescue screen reveals roles for inhibitor of apoptosis proteins in tumor necrosis factor-α signaling
Alex Gaither et al.
CANCER RESEARCH (2007)
Transfection of Smac/DIABLO sensitizes drug-resistant tumor cells to TRAIL or paclitaxel-induced apoptosis in vitro
Hong Luan Mao et al.
PHARMACOLOGICAL RESEARCH (2007)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
IAP antagonists target cIAP1 to induce TNFα- dependent apoptosis
James E. Vince et al.
CELL (2007)
Autocrine TNFα signaling renders human cancer cells susceptible to smac-mimetic-induced apoptosis
Sean L. Petersen et al.
CANCER CELL (2007)
Simian immunodeficiency virus lentivector corrects human X-linked chronic granulomatous disease in the NOD/SCID mouse xenograft
N. Naumann et al.
GENE THERAPY (2007)
Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells
Sharmila Shankar et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2007)
A small molecule Smac mimic potentiates TRAIL-mediated cell death of ovarian cancer cells
Eleonora Petrucci et al.
GYNECOLOGIC ONCOLOGY (2007)
Regulation of the resistance to TRAIL-induced apoptosis in human primary T lymphocytes:: Role of NF-κB inhibition
Jorge Carlos Morales et al.
MOLECULAR IMMUNOLOGY (2007)
COMMD proteins and the control of the NFκB pathway
Gabriel N. Maine et al.
CELL CYCLE (2007)
Targeting mitochondrial factor Smac/DIABLO as therapy for multiple myeloma (MM)
Dharminder Chauhan et al.
BLOOD (2007)
Embelin, an inhibitor of X chromosome-linked inhibitor-of-apoptosis protein, blocks nuclear factor-κB (NF-κB) signaling pathway leading to suppression of NF-κB-regulated antiapoptotic and metastatic gene products
Kwang Seok Ahn et al.
MOLECULAR PHARMACOLOGY (2007)
TRAIL signalling: Decisions between life and death
Christina Falschlehner et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2007)
Design, synthesis, and evaluation of a potent, cell-permeable, conformationally constrained second mitochondria derived activator of caspase (Smac) mimetic
Haiying Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Constitutively activated nuclear factor-κB, but not induced NF-κB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells
Susanne J. Braeuer et al.
MOLECULAR CANCER RESEARCH (2006)
Differential susceptibility to TRAIL of normal versus malignant human urothelial cells
L. P. Steele et al.
CELL DEATH AND DIFFERENTIATION (2006)
APO2 ligand/tumor necrosis factor-related apoptosis-inducing ligand in prostate cancer therapy
O Bucur et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2006)
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases
T Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells
KM Bockbrader et al.
ONCOGENE (2005)
COMMD proteins, a novel family of structural and functional homologs of MURR1
E Burstein et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Mechanisms of resistance to TRAIL-induced apoptosis in cancer
LD Zhang et al.
CANCER GENE THERAPY (2005)
X-linked inhibitor of apoptosis protein (XIAP) is a nonredundant modulator of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in human cancer cells
JM Cummins et al.
CANCER RESEARCH (2004)
Caspase-8 levels affect necessity for mitochondrial amplification in death ligand-induced glioma cell apoptosis
MJ Knight et al.
MOLECULAR CARCINOGENESIS (2004)
A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death
L Li et al.
SCIENCE (2004)
Structure-based design, synthesis, and evaluation of conformationally constrained mimetics of the second mitochondria-derived activator of caspase that target the X-linked inhibitor of apoptosis protein/caspase-9 interaction site
HY Sun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Structure-based design of potent, conformationally constrained Smac mimetics
HY Sun et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2004)
Downregulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis
M Chawla-Sarkar et al.
CELL DEATH AND DIFFERENTIATION (2004)
NF-kappa B activation in human prostate cancer: Important mediator or epiphenomenon?
J Suh et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Discovery of embelin as a cell-permeable, small-molecular weight inhibitor of XLAP through structure-based computational screening of a traditional herbal medicine three-dimensional structure database
Z Nikolovska-Coleska et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity
AD Schimmer et al.
CANCER CELL (2004)
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
A Almasan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Endogenous association of TRAF2, TRAF3, cIAP1, and Smac with lymphotoxin β receptor reveals a novel mechanism of apoptosis
J Kuai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2 L/TRAIL-mediated apoptosis of prostate cancer cells: Role of XIAP in resistance
CP Ng et al.
PROSTATE (2002)
Activation of NF-κB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells:: therapeutic implications
CS Mitsiades et al.
ONCOGENE (2002)
Inhibition of TRAIL-induced apoptosis by Bcl-2 overexpression
S Fulda et al.
ONCOGENE (2002)
Self-assembly of a virus-mimicking nanostructure system for efficient tumor-targeted gene delivery
L Xu et al.
HUMAN GENE THERAPY (2002)
Apoptosis: A link between cancer genetics and chemotherapy
RW Johnstone et al.
CELL (2002)
Targeting apoptosis in prostate cancer
RS DiPaola et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2001)
XIAP: Apoptotic brake and promising therapeutic target
M Holcik et al.
APOPTOSIS (2001)
Structural basis for binding of Smac/DIABLO to the XIAP BIR3 domain
ZH Liu et al.
NATURE (2000)
Structural basis of IAP recognition by Smac/DIABLO
G Wu et al.
NATURE (2000)
Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis
M Irmler et al.
FEBS LETTERS (2000)